Experiments

Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).

• The chromatin remodeller CHD4 regulates transcription factor binding to both prevent activation of silent enhancers and maintain active regulatory elements.

  PMID 41632506 · PMC12867480 · eLife · 2026 · 8 claims · 8 setups

  Full-text index only

  CHD4 acts via a second mechanism beyond nucleosome sliding: actively restricting the residence time of transcription factors on chromatin

  chd4-maid sall1 western flow calibrated

• Short activation domains control chromatin association of transcription factors.

  PMID 41511382 · PMC12788797 · eLife · 2026 · 8 claims · 8 setups

  Full-text index only

  Short activation domains (39-60 aa, only 5-7% of the synthetic TF) dominate the chromatin-bound fraction of a synthetic transcription factor.

  u2os synthetic single-molecule flow fluorescence

• Single-cell resolution of an open chromatin signature in persister tumor cells.

  PMID 41485222 · PMC12978573 · Cell reports · 2026 · 8 claims · 8 setups

  Full-text index only

  Single-nucleus multi-omic (snRNA-seq + snATAC-seq) profiling of fallopian tube, treatment-naive, and NACT-treated HGSOC tissue identifies a persister cell signature (PCS) defining the chemotherapy-tolerant state.

  non-malignant same epithelial tumor single-nucleus mitochondrial copy-number

• CTCF/cohesin-binding sites are susceptible to replication-associated DNA damage and genomic instability in cancer cells.

  PMID 41630911 · PMC12860730 · iScience · 2026 · 8 claims · 8 setups

  Full-text index only

  CTCF and cohesin (RAD21) remain co-bound to DNA throughout interphase, including during the S (replication) phase, in HeLa cells

  hela tumors flow chromatin frap